查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1349401

鼻咽拭子市场（应用：流感、COVID-19、呼吸道合胞病毒、百日咳博德氏菌感染、MRSA 等）- 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Nasopharyngeal Swabs Market (Application: Influenza, COVID-19, Respiratory Syncytial Virus, Bordetella Pertussis Infection, MRSA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

鼻咽拭子市场 - 报告范围

TMR 关于全球鼻咽拭子市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球鼻咽拭子市场的收入2017 -2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球鼻咽拭子市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解鼻咽拭子市场。

市场概况
2023年市场价值 2.673 亿美元
2031 年市场价值 3.286 亿美元
复合年增长率 0.024%

该报告深入研究了全球鼻咽拭子市场的竞争格局。全球鼻咽拭子市场的主要参与者已经确定，并对每个参与者的各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球鼻咽拭子市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 重要行业活动
  • 技术进步
  • 传染病流行病学：依国家分类
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按类型，2017-2031
    • 泡棉棉籤
    • 非织物拭子
    • 其他的
  • 市场吸引力分析：按类型

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 流感
    • 新冠肺炎
    • 呼吸道融合病毒
    • 百日咳博德氏菌感染
    • MRSA（抗甲氧西林金黄色葡萄球菌）
    • 其他的
  • 市场吸引力分析：按应用

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院
    • 诊所
    • 学术界及研究机构
    • 其他的
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分，2022 年
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • CR Bard, Inc. (Becton, Dickinson and Company)
    • Medical Wire & Equipment (MWE)
    • Titan Biotech Ltd.
    • COPAN Diagnostics, Inc.
    • Miraclean Technology Co., Ltd.
    • YOCON Biology
    • Trinity Biotech
    • VIRCELL SL
    • Quidel Corporation
Product Code: TMRGL79856

Nasopharyngeal Swabs Market - Scope of Report

TMR's report on the global nasopharyngeal swabs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nasopharyngeal swabs market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nasopharyngeal swabs market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nasopharyngeal swabs market.

Market Snapshot
Market Value in 2023US$ 267.3 Mn
Market Value in 2031US$ 328.6 Mn
CAGR2.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nasopharyngeal swabs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nasopharyngeal swabs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nasopharyngeal swabs market.

The report delves into the competitive landscape of the global nasopharyngeal swabs market. Key players operating in the global nasopharyngeal swabs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nasopharyngeal swabs market profiled in this report.

Key Questions Answered in Global Nasopharyngeal Swabs Market Report:

  • What is the sales/revenue generated by nasopharyngeal swabs across all regions during the forecast period?
  • What are the opportunities in the global nasopharyngeal swabs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nasopharyngeal Swabs Market - Research Objectives and Research Approach

The comprehensive report on the global nasopharyngeal swabs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nasopharyngeal swabs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nasopharyngeal swabs market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nasopharyngeal Swabs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nasopharyngeal Swabs Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Technological Advancements
  • 5.3. Epidemiology of Infectious Diseases, by Country/Region
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Foam Tipped Swabs
    • 6.3.2. Non-woven Swabs
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Influenza
    • 7.3.2. COVID-19
    • 7.3.3. Respiratory Syncytial Virus
    • 7.3.4. Bordetella Pertussis Infection
    • 7.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Nasopharyngeal Swabs Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Academia & Research Institutes
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Nasopharyngeal Swabs Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Foam Tipped Swabs
    • 10.2.2. Non-woven Swabs
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Influenza
    • 10.3.2. COVID-19
    • 10.3.3. Respiratory Syncytial Virus
    • 10.3.4. Bordetella Pertussis Infection
    • 10.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 10.3.6. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Clinics
    • 10.4.3. Academia & Research Institutes
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Nasopharyngeal Swabs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Foam Tipped Swabs
    • 11.2.2. Non-woven Swabs
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Influenza
    • 11.3.2. COVID-19
    • 11.3.3. Respiratory Syncytial Virus
    • 11.3.4. Bordetella Pertussis Infection
    • 11.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Clinics
    • 11.4.3. Academia & Research Institutes
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Nasopharyngeal Swabs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Foam Tipped Swabs
    • 12.2.2. Non-woven Swabs
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Influenza
    • 12.3.2. COVID-19
    • 12.3.3. Respiratory Syncytial Virus
    • 12.3.4. Bordetella Pertussis Infection
    • 12.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Clinics
    • 12.4.3. Academia & Research Institutes
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Nasopharyngeal Swabs Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Foam Tipped Swabs
    • 13.2.2. Non-woven Swabs
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Influenza
    • 13.3.2. COVID-19
    • 13.3.3. Respiratory Syncytial Virus
    • 13.3.4. Bordetella Pertussis Infection
    • 13.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Clinics
    • 13.4.3. Academia & Research Institutes
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Nasopharyngeal Swabs Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Foam Tipped Swabs
    • 14.2.2. Non-woven Swabs
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Influenza
    • 14.3.2. COVID-19
    • 14.3.3. Respiratory Syncytial Virus
    • 14.3.4. Bordetella Pertussis Infection
    • 14.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Clinics
    • 14.4.3. Academia & Research Institutes
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Thermo Fisher Scientific, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company)
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Medical Wire & Equipment (MWE)
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Titan Biotech Ltd.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. COPAN Diagnostics, Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Miraclean Technology Co., Ltd.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Puritan Medical Products
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. YOCON Biology
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Trinity Biotech
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. VIRCELL S.L.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Quidel Corporation
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview

List of Tables

  • Table 1: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 2: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 3: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 4: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 5: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 6: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 7: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 8: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 9: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 10: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 13: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 14: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 17: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 18: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 21: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 22: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 24: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031

List of Figures

  • Figure 01: Global Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Nasopharyngeal Swabs Market Value Share, by Type, 2022
  • Figure 03: Global Nasopharyngeal Swabs Market Value Share, by Application, 2022
  • Figure 04: Global Nasopharyngeal Swabs Market Value Share, by End-user, 2022
  • Figure 05: Global Nasopharyngeal Swabs Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 06: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Foam Tipped Swabs, 2017-2031
  • Figure 07: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Non-woven Swabs, 2017-2031
  • Figure 08: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 10: Global Nasopharyngeal Swabs Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 11: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Influenza, 2017-2031
  • Figure 12: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by COVID-19, 2017-2031
  • Figure 13: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Respiratory Syncytial Virus, 2017-2031
  • Figure 14: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Bordetella Pertussis Infection, 2017-2031
  • Figure 15: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by MRSA (Methicillin-Resistant Staphylococcus aureus), 2017-2031
  • Figure 16: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 18: Global Nasopharyngeal Swabs Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 20: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Clinics 2017-2032
  • Figure 21: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 22: Global Nasopharyngeal Swabs Market Revenue (US$ Mn), by Academia & Research Institutes
  • Figure 23: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 24: Global Nasopharyngeal Swabs Market Value Share Analysis, by Region 2022 and 2031
  • Figure 25: Global Nasopharyngeal Swabs Market Attractiveness Analysis, by Region 2023-2031
  • Figure 26: North America Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 27: North America Nasopharyngeal Swabs Market Value Share Analysis, by Country 2022 and 2031
  • Figure 28: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Country 2023-2031
  • Figure 29: North America Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 30: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 31: North America Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 32: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 33: North America Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 34: North America Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 35: Europe Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 36: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 37: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 39: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 40: Europe Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 41: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 42: Europe Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 43: Europe Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 44: Asia Pacific Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 45: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 46: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 48: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 49: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 50: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 51: Asia Pacific Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 52: Asia Pacific Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 53: Latin America Nasopharyngeal Swabs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 54: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 57: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Type 2023-2031
  • Figure 58: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 59: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by Application 2023-2031
  • Figure 60: Latin America Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 61: Latin America Nasopharyngeal Swabs Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 62: Middle East and Africa Nasopharyngeal Swabs Market Value (US$ Mn), 2017-2031
  • Figure 63: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 64: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Country/Sub-region, 2023-2031
  • Figure 65: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Type 2022 and 2031
  • Figure 66: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Type 2023-2031
  • Figure 67: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by Application 2022 and 2031
  • Figure 68: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness, by Application 2023-2031
  • Figure 69: Middle East and Africa Nasopharyngeal Swabs Market Value Share Analysis, by End-user 2022 and 2031
  • Figure 70: Middle East and Africa Nasopharyngeal Swabs Market Attractiveness by End-user 2023-2031
  • Figure 71: Company Share Analysis Nasopharyngeal Swabs, 2022